Edition:
United Kingdom

People: Agile Therapeutics Inc (AGRX.OQ)

AGRX.OQ on NASDAQ Stock Exchange Capital Market

1.49USD
5:04pm BST
Change (% chg)

$0.02 (+1.36%)
Prev Close
$1.47
Open
$1.46
Day's High
$1.50
Day's Low
$1.46
Volume
6,869
Avg. Vol
81,798
52-wk High
$2.98
52-wk Low
$0.23

Altomari, Alfred 

Mr. Alfred Altomari serves as Chairman of the Board, President, Chief Executive Officer of Agile Therapeutics, Inc. From 2008 to September 2010, Mr. Altomari was also a consultant to Agile. From 2003 to 2008, Mr. Altomari held multiple senior management positions at Barrier Therapeutics, Inc., including Chief Commercial Officer, Chief Operating Officer, and Chief Executive Officer. In 2008, in his role as Chief Executive Officer and as a member of Barrier's board of directors, Mr. Altomari completed the successful sale of Barrier to Stiefel Laboratories, which was subsequently acquired by GlaxoSmithKline plc. From 1982 to 2003, Mr. Altomari held numerous executive roles in general management, commercial operations, business development, product launch preparation, and finance with Johnson & Johnson. Mr. Altomari also serves on the board of directors of Insmed Inc. and Recro Pharma, Inc.

Basic Compensation

Total Annual Compensation, USD 492,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 516,917
Fiscal Year Total, USD 1,008,920

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --